Stockreport

Eye-Disease Focused Kodiak Sciences Is A Promising 'Turnaround Story For 2025': Analyst Upgrades Stock [Yahoo! Finance]

Kodiak Sciences Inc  (KOD) 
Last kodiak sciences inc earnings: 11/12 05:30 am Check Earnings Report
PDF Kodiak's lead medicine, tarcocimab, is being studied in two Phase 3 trials for retinal diseases and has shown strong potential. The company's stock is considered underva [Read more]